TY - JOUR
T1 - Comparison of 2-year outcomes between primary and secondary prophylactic use of defibrillators in patients with coronary artery disease
T2 - A prospective propensity score–matched analysis from the Nippon Storm Study
AU - Kondo, Yusuke
AU - Noda, Takashi
AU - Sato, Yasunori
AU - Ueda, Marehiko
AU - Nitta, Takashi
AU - Aizawa, Yoshifusa
AU - Ohe, Tohru
AU - Kurita, Takashi
N1 - Publisher Copyright:
© 2021 Heart Rhythm Society
PY - 2021/2
Y1 - 2021/2
N2 - Background: The Nippon Storm Study was a prospective observational study designed to gather clinical data on implantable cardioverter-defibrillator (ICD) therapy in Japanese patients. Objective: The purpose of this subanalysis was to compare the incidence of ICD therapy in patients with left ventricular dysfunction owing to coronary artery disease (CAD) for primary and secondary prophylaxis of sudden cardiac death. Methods: We analyzed data of 493 patients with CAD and ICDs (men, 87%; age, 68 ± 10 years; left ventricular ejection fraction, 36% ± 13%; primary prophylaxis, 36%). All patients were followed up for at least 2 years. Propensity score matching was used to select patient subgroups for comparison: 133 patients with ICD for primary prophylaxis and 133 with ICD for secondary indications. Results: There were no significant differences between primary and secondary prophylaxis groups with respect to the incidence of appropriate ICD therapy within 2 years (0.153 vs 0.239; hazard ratio, 1.565 [95% confidence interval (CI), 0.898–2.727]; P = .114). Two-year electrical storm risks were 3.3% and 9.6% with HR = 3.236 (95% CI, 1.058–9.896; P = .039) in patients with primary and secondary prophylaxis, respectively. Conclusion: The incidence of ICD therapy received by patients with CAD for primary and secondary prophylaxis was not significantly different based on our propensity score–matched analysis. However, secondary-prophylaxis ICD therapy seems to be associated with a significantly higher risk for electrical storm than primary-prophylaxis ICD therapy.
AB - Background: The Nippon Storm Study was a prospective observational study designed to gather clinical data on implantable cardioverter-defibrillator (ICD) therapy in Japanese patients. Objective: The purpose of this subanalysis was to compare the incidence of ICD therapy in patients with left ventricular dysfunction owing to coronary artery disease (CAD) for primary and secondary prophylaxis of sudden cardiac death. Methods: We analyzed data of 493 patients with CAD and ICDs (men, 87%; age, 68 ± 10 years; left ventricular ejection fraction, 36% ± 13%; primary prophylaxis, 36%). All patients were followed up for at least 2 years. Propensity score matching was used to select patient subgroups for comparison: 133 patients with ICD for primary prophylaxis and 133 with ICD for secondary indications. Results: There were no significant differences between primary and secondary prophylaxis groups with respect to the incidence of appropriate ICD therapy within 2 years (0.153 vs 0.239; hazard ratio, 1.565 [95% confidence interval (CI), 0.898–2.727]; P = .114). Two-year electrical storm risks were 3.3% and 9.6% with HR = 3.236 (95% CI, 1.058–9.896; P = .039) in patients with primary and secondary prophylaxis, respectively. Conclusion: The incidence of ICD therapy received by patients with CAD for primary and secondary prophylaxis was not significantly different based on our propensity score–matched analysis. However, secondary-prophylaxis ICD therapy seems to be associated with a significantly higher risk for electrical storm than primary-prophylaxis ICD therapy.
KW - Coronary artery disease
KW - Implantable cardioverter-defibrillator
KW - Nippon Storm Study
KW - Primary prophylaxis
KW - Secondary prophylaxis
UR - http://www.scopus.com/inward/record.url?scp=85108779732&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85108779732&partnerID=8YFLogxK
U2 - 10.1016/j.hroo.2020.12.020
DO - 10.1016/j.hroo.2020.12.020
M3 - Article
AN - SCOPUS:85108779732
SN - 2666-5018
VL - 2
SP - 5
EP - 11
JO - Heart Rhythm O2
JF - Heart Rhythm O2
IS - 1
ER -